Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. JBLU
6. ANT
7. AAPL
8. SSD
9. ARTV
10. AGYS

Go back to Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook

CONMED (CNMD) PT Raised to $83 at Needham & Company

August 2, 2018 6:43 AM EDT

Needham & Company raised its price target on CONMED (NASDAQ: CNMD) to $83.00 (from $73.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "CNMD's 2Q18 revenue and EPS beat consensus and management raised its 2018 revenue and maintained its EPS guidance. Revenue growth improved... More